Literature DB >> 2433211

Biological properties and molecular biology of the human macrophage growth factor, CSF-1.

P Ralph, M K Warren, I Nakoinz, M T Lee, L Brindley, A Sampson-Johannes, E S Kawasaki, M B Ladner, J E Strickler, A Boosman.   

Abstract

CSF-1 is a growth and differentiation factor for the production of mononuclear phagocytes from undifferentiated bone marrow progenitors. In addition to previously described effects on mature cells, we show here that CSF-1 stimulates the production by monocytes of interferon, tumor necrosis factor, and myeloid CSF that produces mainly mixed neutrophil-macrophage colonies in bone marrow culture. Pretreatment with CSF-1 also promotes resistance to viral infection and tumor cytotoxicity in murine peritoneal macrophages. Based on amino acid sequence data of purified human urinary and murine L cell CSF-1, we have cloned the complementary DNA (cDNA) from messenger RNA (mRNA) of the human CSF-1 producing MIA PaCa cell line. The cDNA specifies a 32 amino acid signal peptide followed by a protein of 224 amino acids. Several facts suggest, however, that one-third of the molecule at the C-terminal end is processed off intracellularly to derive the secreted growth factor. The gene is about 18 kilobases (kb) in length and contains 9 exons. Although there appears to be a single copy gene for CSF-1, cells expressing the factor contain several mRNA species, suggesting that the gene may have several functions or levels of regulation. High level expression of the recombinant protein will allow preclinical testing in several disease models for therapeutic efficacy that has been suggested from in vitro and in vivo biological properties of CSF-1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433211     DOI: 10.1016/S0171-2985(86)80099-7

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

Review 1.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

Review 2.  Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry.

Authors:  R Ross
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

3.  Hematopoietic growth factor receptors.

Authors:  J H Shieh; M A Moore
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

4.  Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice.

Authors:  A G Doyle; W J Halliday; C J Barnett; T L Dunn; D A Hume
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  Human recombinant macrophage colony-stimulating factor (M-CSF) increases Cl-esterase inhibitor (Cl-INH) synthesis by human monocytes.

Authors:  B Schmidt; G Gyapay; M Válay; G Füst
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

6.  Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans.

Authors:  M E Rosenfeld; S Ylä-Herttuala; B A Lipton; V A Ord; J L Witztum; D Steinberg
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

7.  Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.

Authors:  D H Munn; N K Cheung
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.